According to a report by Reuters on Friday, authorities in the Philippines tied at least three deaths to the 2016 deployment of Dengvaxia, the world's first dengue fever vaccine. In November, vaccine manufacturer Sanofi Pasteur admitted that the vaccine, might increase the odds of severe illness in inoculated children who had not previously been infected with the virus. Reuters reports that Sanofi wrote, “We sympathise with all the families who have suffered the loss of a child. Sanofi Pasteur’s mission is to reduce or eliminate suffering for millions around the world through vaccination, including in the Philippines.”